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To the Editor: The importance of 
nontuberculous mycobacteria (NTM) 
in various clinical situations recently 
has increased. Members of the My-
cobacterium avium complex (MAC) 
cause a high percentage of infections 
in persons with acquired immunode-
ﬁ  ciency syndrome. Some species are 
considered emerging pathogens, par-
ticularly those of the M. chelonae–M. 
abscessus group. They occur not only 
in immunocompromised persons but 
also in persons without predispos-
ing conditions. Although sources of 
infection are considered to originate 
from the human environment, until 
now cooling towers were not clearly 
demonstrated to be one of these con-
tamination sources, despite being sus-
pected (1). Natural streams, ground-
water, brook waters, and swamps 
already were reported to contain dif-
ferent species of NTM. Constructed 
environments, such as hospital hot 
water systems, aerosols from showers, 
ice machines, swimming pools, dental 
unit water, endoscopes, and broncho-
scopes are other sources (2). Other 
studies have shown members of MAC 
in drinking-water distribution systems 
(3).
A 1999 study in South Africa re-
ported the presence of mycobacteria in 
cooling towers but reported no details 
about species (4). In 2003, cooling 
towers were reported to be a potential 
source of slow-growing mycobacterial 
species (1). Some mycobacterial spe-
cies recently were shown to survive 
within amebae (5). We aimed to study 
the population of ameba-associated 
mycobacterial species in 3 cooling 
towers using a co-coculture method.
These cooling towers (E, H, and 
O), located in downtown Paris, France, 
were sampled in May 2006. Water was 
taken in a sample point of the cooling 
circuit located just before the entrance 
of the tower basins. Because these 
cooling towers are regularly treated by 
oxidizing biocide BCDMH (1-bromo-
3-chloro-5, 5-dimethylhydantoin) to 
prevent development of Legionella 
spp., no Legionella spp. or Legionella-
like amebal pathogens were isolated.
Two liters of water samples were 
ﬁ  ltrated  through  0.22-μm pore-sized 
ﬁ  lters that were injected onto amebal 
microplates as previously described (6) 
and incubated at 32°C. We screened 
amebal microplates by examination un-
der inverted microscope and by Ziehl-
Nielsen, Gram, and Gimenez staining. 
Positive wells were subcultured on ax-
enic medium and incubated at 32°C for 
10 days. Acid-fast isolates were identi-
ﬁ  ed by using partial rpoB gene ampliﬁ  -
cation and sequencing with Myco-F and 
Myco-R primers (7). These primers did 
not allow ampliﬁ  cation of partial rpoB 
gene for the 6 M. phocaicum strains. 
We thus used Myco-F/Myco-Rbon 
(5′-AGCGGCTGCTGGGTGATCAT- 
3′) primer pair for M. phocaicum (8). 
We compared these sequences with 
the rpoB gene sequence of Mycobac-
teria type strains available in the Gen-
eBank database by using BLASTn on 
the NCBI website (www.ncbi.nlm.nih.
gov).
We observed bacteria growing in 
amebae. Subculture on axenic media 
led to polymicrobial cultures and al-
lowed isolation of 33 mycobacterial 
strains (Table). All these strains were 
submitted to molecular identiﬁ  cation. 
The 33 isolates corresponded to 5 
mycobacterial species: M. fortuitum, 
M. conceptionense, M. chelonae, M. 
chimaera, and M. phocaicum (Table). 
Some of these mycobacteria already 
had been shown to survive in free-
living amebae and to be implicated in 
human diseases, such as M. chelonae 
(5). The same author demonstrated 
recently that 26 environmental myco-
bacteria survived in the trophozoites 
and cysts of Acanthamoeba polypha-
ga ( 5). The recently described spe-
cies M. phocaicum was isolated only 
in samples from humans and was as-
sociated with chronic pneumonia (9). 
However, the natural source of this 
species is still unknown. M. fortuitum 
was described as an opportunistic My-
cobacterium associated with dissemi-
nated infections in a leukemia patient 
or in furunculosis after footbath in nail 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 1, January 2009  121 
Table. Identification of isolated nontuberculous mycobacteria according to their rpoB gene sequence similarity and GenBank 
accession numbers 
Closest officially described 
species (rpoB) Isolates (no.), N = 33 
Range in % gene similarity to type 
strain (GenBank accession no.) 
Accession numbers of
sequences of isolates 
Mycobacterium chelonae O (2), E (2)  99.7 (AY147163)  EU770577
M. conceptionense O (12)  99.2–99.9 (AY859695)  EU770583, EU770584 
M. fortuitum E (2), H (5), O (3)  99.5–99.7 (AY147165)  EU770578, EU770579, EU770580 
M. chimaera H (1)  99.7 (EF521908)  EU770576
M. phocaicum E (5), O (1)  98.3–98.6 (AY859693)  EU770581, EU770582 LETTERS
salons. M. conceptionense belongs to 
the M. fortuitum group and was iso-
lated in a posttraumatic osteitis inﬂ  am-
mation (10). M. chimaera belongs to 
MAC and has been isolated only in pa-
tients with pulmonary disorders but not 
from immunocompromised patients. 
The authors reported that the isolate 
showed unusually high virulence. We 
isolated this species for the ﬁ  rst time 
in an environmental sample. It could 
belong to the transitory ﬂ  ora of the H 
cooling tower because it was isolated 
only once in our samples. Cooling 
towers already had been investigated 
for slow-growing mycobacteria (1), 
and our study showed they also can 
be an environmental source of rapidly 
growing NTM pathogens. In our pro-
cedure for amebal co-cultures, incu-
bation cannot last >10 days because 
amebae do not survive longer in Page’s 
amebal saline buffer. Moreover, agar 
plates were incubated for 10 days only, 
which explains why we could recover 
only rapidly growing mycobacteria. 
The cooling towers, already known as 
a source of dissemination of Legionel-
la spp., may disseminate mycobacteria 
in aerosols and be a previously nonrec-
ognized source of infection.
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Clostridium 




To the Editor: The threat to pub-
lic health posed by Clostridium dif-
ﬁ  cile-associated disease (CDAD) con-
tinues to increase within and outside 
the United States. In a recent analysis, 
we detected a 23% annual increase in 
CDAD-related hospitalizations from 
2000 through 2005 and a near-dou-
bling in the associated age-adjusted 
case-fatality rate from 2000 through 
2004 (1). In view of the aging US pop-
ulation, this rapid growth, along with 
the increased virulence and diminished 
susceptibility to antimicrobial drug 
treatments, if sustained, will not only 
strain the US healthcare system (2,3) 
but also will cause signiﬁ  cant illness 
and death. For this reason, understand-
ing up-to-date trends in CDAD-related 
hospitalizations is critical. Since the 
Agency for Healthcare Research and 
Quality recently made available its 
2006 update to the National Inpatient 
Sample (NIS) data (4) on the Health-
care Costs and Utilization Project Net 
(HCUPNet) website (5), I explored 
the trends in CDAD hospitalizations 
beyond our 2005 estimates.
From the HCUPNet website (5), 
I identiﬁ  ed CDAD-related hospitaliza-
tions for 2000–2006 in the NIS data 
(4). The NIS is a stratiﬁ  ed 20% sam-
ple of US community hospitals, and 
data are weighted to provide national 
estimates (4). CDAD was identiﬁ  ed 
by presence of the International Clas-
siﬁ   cation of Diseases, 9th revision, 
Clinical Modiﬁ  cation  (ICD-9-CM) 
diagnosis code 8.45 (intestinal infec-
tion with Clostridium difﬁ  cile), and 
the numbers of discharges per year 
were age-stratiﬁ  ed.  To  benchmark 
CDAD incidence against the general 
growth in hospitalizations over time, 
I obtained age-stratiﬁ   ed numbers of 
total hospitalizations from HCUPNet 
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